SILibinin in NSCLC and BC Patients With Single Brain METastasis (SILMET)

Clinical trial NCT05689619 · RECRUITING

Trial details

NCT number: NCT05689619
Sponsor: A.O.U. Città della Salute e della Scienza
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Brain Metastases, Adult Non Small Cell Lung Cancer Breast Cancer

Start date: 2023-09-01
Primary completion: 2025-09-01
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.